Viridian Executive Discusses FDA Approval of New TED Therapy
An executive from Viridian discusses the FDA approval of Lumvoa for thyroid eye disease (TED); a biosimilar referencing Lucentis is relaunched in the US; and Lumibird introduces a wireless integrated laser-indirect-ophthalmoscope. Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Eyewire News: The Podcast
FDA Approves Outlook's Lytenava for Wet AMD
PRIMA Retinal Implant Launched in EU
Tarsus Buys Investigational Ocular Antiseptic
Ocular Updates Plans for Axpaxli NDA for Wet AMD
Get summaries like this every morning.
Free AI-powered recaps of Eyewire News: The Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.